Johnson & Johnson working on vaccine for deadly coronavirus
Johnson & Johnson also began work on developing a vaccine for a new coronavirus that has already killed more than 100 people in China, Reuters reports.
J&J said its vaccine program would utilize the same technologies used to make its experimental Ebola vaccine, which is currently being administered in the Democratic Republic of Congo and Rwanda.
Three separate research teams backed by a global coalition set up to fight epidemic diseases last week said they will start work on developing potential vaccines against the new coronavirus.
The research will be conducted by drug developers Moderna, Inovio Pharma, and a team at the University of Queensland, Australia.
Gilead Sciences last week said it was assessing whether its experimental Ebola treatment could be used against the coronavirus.
J&J also said it had donated its HIV drug Prezcobix to China for use in research to find a solution against the outbreak.